Hpv Vaccine
Hpv Vaccine - most related articles:
-
Many parents, high priority adults didn't get H1N1 vaccine - 4.3
-
Universal Influenza vaccine holds promise - 4.3
-
Universal influenza vaccine possible in future - 4.1
-
Swine flu vaccine causing sudden sleep disorder narcolepsy in children - 4.1
-
New bird flu vaccine may give long-term defense - 3.9
-
Sanofi Pasteur's New Influenza Vaccine Plant, US - 3.9
-
Swine flu vaccine trials under way, UK - 3.9
-
Swine flu vaccine candidate prepared by UK - 3.8
-
HPV vaccine's hypersensitivity reactions are rare - 3.7
-
Ixiaro to prevent Japanese Encephalitis approved in Europe - 3.7
Hpv Vaccine articles
HPV vaccine reduces subsequent cervical disease in womenHPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.
Benefit to women not enough to sway men to get HPV vaccineInforming men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study.
Gardasil efficacious against HPV 16 infectionIn a study of an extended follow up of 290 women naïve to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 infection for an average of 8.5 years after administration.
Cervical cancer screening might safely be delayed after HPV vaccineDNA from human papilloma virus type 16 (HPV16) and HPV type 18 (HPV18) were found in the majority of invasive cervical cancers in New Mexico in the 1980s and 1990s, according to a population-based study published in the March 24 online issue of the Journal of the National Cancer Institute.
HPV vaccine's hypersensitivity reactions are rareHypersensitivity reactions to the quadrivalent HPV vaccine (4vHPV, Gardasil) are uncommon and most schoolgirls can tolerate subsequent doses, finds the first evaluation of the quadrivalent HPV vaccine published on bmj.com.
Gardasil HPV vaccine prevented genital lesions in menGARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.
HPV vaccine Cervarix in UK's immunisation programmeThe UK's leading cervical cancer charity, Jo's Trust, has welcomed the UK's Department of Health's announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.
Mothers less likely to vaccinate daughters against HPVU.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve mom's acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study.
Gardasil HPV vaccine reduces abnormal pap test resultsA significant drop in abnormal Pap test results happened after girls and women were given Gardasil vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).
9 Hpv Vaccine articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.